Shuttle Pharmaceuticals Inc (SHPH) — Strategic Asset Allocation Index
Shuttle Pharmaceuticals Inc (SHPH) has a Strategic Asset Allocation Index of 0.7% as of March 2023. Strategic assets (PP&E of $50.93K plus long-term investments of $-) total $50.93K, measured against net assets of $6.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Shuttle Pharmaceuticals Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shuttle Pharmaceuticals Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how Shuttle Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2018 to 2022. As of March 2023, the index stands at 0.7%, representing strategic assets of $50.93K against net assets of $6.91 Million USD. For live market cap and overall valuation, see Shuttle Pharmaceuticals Inc (SHPH) total market value.
Annual Strategic Asset Allocation Index for Shuttle Pharmaceuticals Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shuttle Pharmaceuticals Inc from 2018 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Shuttle Pharmaceuticals Inc (SHPH) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.9% | $68.71K | $68.71K | $- | $7.68 Million | ▼ -2.2 pp |
| 2018 | 3.1% | $838.00 | $838.00 | $- | $27.46K | — |